delta-8-tetrahydrocannabinol and Glioma

delta-8-tetrahydrocannabinol has been researched along with Glioma* in 1 studies

Other Studies

1 other study(ies) available for delta-8-tetrahydrocannabinol and Glioma

ArticleYear
Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs.
    Bioorganic & medicinal chemistry, 2008, Jul-01, Volume: 16, Issue:13

    The synthesis and characterization of novel C1'-phenyl-substituted Delta(8)-THC analogs were previously reported by our laboratory. Within this small series of compounds, the C1'-dimethyl phenyl group was found to impart 13.5-fold selectivity for the CB2 receptor with a K(i) 0.91 nM. The current study expands on the previous report by evaluating the effects of aromatic ring substitution on CB1 and CB2 receptor subtype binding and selectivity. The ring substituents synthesized in this study include aliphatic, halogen, nitrile, and acetamido functional groups. In addition, the isosteric replacement of the phenyl group by thiophene was evaluated. The anti-glioma activities of selected compounds were evaluated in vitro and compared to the lead compound 2.

    Topics: Cell Line; Cell Survival; Dronabinol; Glioma; Humans; Methylation; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2008